Finance
Results: 32137-32148 of 39668

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories

Elda River Capital Management Completes Successful Spin-Out and Launch of Independent Real Assets Investment Firm





